Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
28 Results for "
OX40 receptor
" in MedChemExpress (MCE) Product Catalog:
Products (28)
28 Results for "OX40 receptor" in MCE Product Catalog:
1
1 Cited Publications
Cat. No.: HY-P78189
Purity: ≥ 95%, as determined by Bis-Tris PAGE.
Synonyms: TNFRSF4; CD134 Antigen; Prev. TXGP1L; Tumor Necrosis Factor receptor Superfamily, Member 4; Tumor Necrosis Factor receptor Superfamily Member 4; Lymphoid Activation Antigene ACT35; OX40L receptor; OX40 Cell Surface Antigen; ACT35; OX40 Homologue; CD134; A
Cat. No.: HY-P99570
CAS No.: 2126777-87-3
Synonyms: GBR-830
Target:
Research Areas:
Cat. No.: HY-P99159
CAS No.: 2128729-41-7
Target:
Research Areas:
Cat. No.: HY-P991336
CAS No.: 2708115-83-5
Synonyms: INBRX-106; ES-102
Target:
Research Areas:
Synonyms: N-Vanillylarachidonamide
Research Areas:
Arvanil (N-Vanillylarachidonamide) is a mixed agonist of CB1 and TRPV1 receptors. Arvanil downregulates CD25, HLA-DR, CD134/OX40, blocks G1/S phase transition, and induces phosphorylation of Akt. Arvanil does not induce apoptosis in cells. Arvanil inhibits lymphocyte activation and ameliorates autoimmune encephalomyelitis. Arvanil can be used in research related to Huntington's disease, vomiting, and multiple sclerosis .
Cat. No.: HY-P99945
CAS No.: 2230138-89-1
Synonyms: ABBV-368
Target:
Research Areas:
Cat. No.: HY-P991338
Target:
Research Areas:
Cat. No.: HY-151506
CAS No.: 2274812-94-9
Cat. No.: HY-P99911
CAS No.: 1635395-27-5
Synonyms: MEDI-6383
Target:
Research Areas:
Cat. No.: HY-P991529
Target:
Research Areas:
Cat. No.: HY-P7394
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: TNFRSF4; CD134 Antigen; Prev. TXGP1L; Tumor Necrosis Factor receptor Superfamily, Member 4; Tumor Necrosis Factor receptor Superfamily Member 4; Lymphoid Activation Antigene ACT35; OX40L receptor; OX40 Cell Surface Antigen; ACT35; OX40 Homologue; CD134; A
Cat. No.: HY-P70813
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: TNFRSF4; CD134 Antigen; Prev. TXGP1L; Tumor Necrosis Factor receptor Superfamily, Member 4; Tumor Necrosis Factor receptor Superfamily Member 4; Lymphoid Activation Antigene ACT35; OX40L receptor; OX40 Cell Surface Antigen; ACT35; OX40 Homologue; CD134; A
Cat. No.: HY-P72499
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: TNFRSF4; CD134 Antigen; Prev. TXGP1L; Tumor Necrosis Factor receptor Superfamily, Member 4; Tumor Necrosis Factor receptor Superfamily Member 4; Lymphoid Activation Antigene ACT35; OX40L receptor; OX40 Cell Surface Antigen; ACT35; OX40 Homologue; CD134; A
Cat. No.: HY-P78334
Purity: ≥ 95%, as determined by Bis-Tris PAGE.
Synonyms: TNFRSF4; CD134 Antigen; Prev. TXGP1L; Tumor Necrosis Factor receptor Superfamily, Member 4; Tumor Necrosis Factor receptor Superfamily Member 4; Lymphoid Activation Antigene ACT35; OX40L receptor; OX40 Cell Surface Antigen; ACT35; OX40 Homologue; CD134; A
Cat. No.: HY-P78188
Purity: ≥ 95%, as determined by Bis-Tris PAGE.
Synonyms: TNFRSF4; CD134 Antigen; Prev. TXGP1L; Tumor Necrosis Factor receptor Superfamily, Member 4; Tumor Necrosis Factor receptor Superfamily Member 4; Lymphoid Activation Antigene ACT35; OX40L receptor; OX40 Cell Surface Antigen; ACT35; OX40 Homologue; CD134; A
Cat. No.: HY-P78503
Purity: ≥ 95%, as determined by Bis-Tris PAGE.
Synonyms: TNFRSF4; CD134 Antigen; Prev. TXGP1L; Tumor Necrosis Factor receptor Superfamily, Member 4; Tumor Necrosis Factor receptor Superfamily Member 4; Lymphoid Activation Antigene ACT35; OX40L receptor; OX40 Cell Surface Antigen; ACT35; OX40 Homologue; CD134; A
Cat. No.: HY-P704275
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: TNFRSF4; CD134 Antigen; Prev. TXGP1L; Tumor Necrosis Factor receptor Superfamily, Member 4; Tumor Necrosis Factor receptor Superfamily Member 4; Lymphoid Activation Antigene ACT35; OX40L receptor; OX40 Cell Surface Antigen; ACT35; OX40 Homologue; CD134; A
Cat. No.: HY-P70549
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: TNFRSF4; CD134 Antigen; Prev. TXGP1L; Tumor Necrosis Factor receptor Superfamily, Member 4; Tumor Necrosis Factor receptor Superfamily Member 4; Lymphoid Activation Antigene ACT35; OX40L receptor; OX40 Cell Surface Antigen; ACT35; OX40 Homologue; CD134; A
Species:
Source:
Cat. No.: HY-P75954
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: TNFRSF4; CD134 Antigen; Prev. TXGP1L; Tumor Necrosis Factor receptor Superfamily, Member 4; Tumor Necrosis Factor receptor Superfamily Member 4; Lymphoid Activation Antigene ACT35; OX40L receptor; OX40 Cell Surface Antigen; ACT35; OX40 Homologue; CD134; A
Species:
Source:
Cat. No.: HY-P72404
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: TNFRSF4; CD134 Antigen; Prev. TXGP1L; Tumor Necrosis Factor receptor Superfamily, Member 4; Tumor Necrosis Factor receptor Superfamily Member 4; Lymphoid Activation Antigene ACT35; OX40L receptor; OX40 Cell Surface Antigen; ACT35; OX40 Homologue; CD134; A
- 1
- 2
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
